Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02869282

Circulating And Intra-Tumoral Chemokines In Patients With Prostate Cancer

Study Of The Expression Of Circulating And Intra-Tumoral Chemokines In Patients With Prostate Cancer

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Institut Bergonié · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Multicentric, observational, prospective, non-interventional study with occasional biological sample collection (serum bank, urine bank and tumor bank)

Detailed description

This project is an exploratory study, based on the hypothesis of involvement of chemokines in hormonal escape of prostate cancers. The two main objectives are: * To describe the variations in expression of chemokines in serum and urine level in patients with prostate cancer * And to study the disease stage and intra-prostatic concentrations of chemokines based on serum and urine concentrations of chemokines before treatment initiation. These estimates can be used in future trials set up for the management of prostate cancer

Conditions

Interventions

TypeNameDescription
OTHERBlood samplesAdditional blood samples at baseline, 6, 12, 18 and 24 months.
OTHERUrine samplesAdditional urine samples at baseline, 6, 12, 18 and 24 months.

Timeline

Start date
2011-06-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2016-08-16
Last updated
2025-09-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02869282. Inclusion in this directory is not an endorsement.

Circulating And Intra-Tumoral Chemokines In Patients With Prostate Cancer (NCT02869282) · Clinical Trials Directory